T 0548/16 (Sustained analgesia with buprenorphine / EURO-CELTIQUE) of 17.01.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T054816.20200117
- Date of decision
- 17 January 2020
- Case number
- T 0548/16
- Online on
- 30 January 2020
- Petition for review of
- -
- Application number
- 06118876.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Sustained analgesia achieved with transdermal delivery of buprenorphine
- Applicant name
- EURO-CELTIQUE S.A.
Mundipharma Laboratories GmbH
Napp Pharmaceutical Holdings Limited
Mundipharma Pharmaceuticals B.V.
Mundipharma AB
Mundipharma Pharmaceuticals Limited
Norpharma A/S
Mundipharma OY - Opponent name
- Hexal AG
Gallafent, Alison
tesa Labtec GmbH - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.